Global Medical Gas Market

Medical Gas Market Size, Share, Growth Analysis, By Product (Pure Gases, Gas Mixtures), By Application (Therapeutic, Diagnostics), By End Use (Hospitals, Ambulatory Surgical Centers), By Region - Industry Forecast 2025-2032

Report ID: SQSG35B2022 | Region: Global | Published Date: December, 2024
Pages: 165 | Tables: 88 | Figures: 76

Medical Gas Market Competitive Landscape

Due to the existence of a small number of significant companies, the market is moderately consolidated. Leading players also participate in partnerships, product launches, mergers, and acquisitions to expand their product lines. For instance, Air Liquide S.A. agreed to buy South Africa's biggest oxygen production facility in June 2021. Strategically, Air Liquide and Sasol agreed that Air Liquide would acquire and run the plant. This plan is expected to improve the company's total manufacturing capability and solidify its position in the market. As a result, the market is expected to grow over the course of the projected period thanks to various strategies adopted by top players. The following are a few of the leading companies in the medical gas market.

Medical Gas Market Top Player’s Company Profiles

  • Linde plc (UK) 
  • Air Liquide (France) 
  • Taiyo Nippon Sanso Corporation (Japan) 
  • Air Products and Chemicals, Inc. (USA) 
  • Atlas Copco AB (Sweden) 
  • Messer Group GmbH (Germany) 
  • Matheson Tri-Gas Inc. (USA) (owned by Taiyo Nippon Sanso) 
  • SOL S.p.A. (Italy) 
  • GCE Group (Sweden) 
  • Amico Group of Companies (Canada) 
  • Praxair, Inc. (USA) (merged with Linde) 
  • INOX Air Products Pvt Ltd (India) 
  • Norco, Inc. (USA) 
  • Genstar Technologies Company, Inc. (USA) 
  • Southern Gas Limited (India) 
  • Calox Inc. (USA) 
  • Ellenbarrie Industrial Gases Ltd. (India) 
  • Steelman Gases Pvt. Ltd. (India) 
  • Butler Gas Products Company (USA) 
  • SCI Analytical, Inc. (USA) 

Medical Gas Market Recent Development

  • In June 2021, For the purpose of expanding its presence in the market for home healthcare, Air Liquide bought EOVE (France). A new business called EOVE is focused on producing ventilators for people with chronic respiratory failure who live at home.
  • In April 2021, ALPIFLOW, a next-generation flow meter with a lifespan of more than ten years without additional maintenance, was introduced by Ceodeux Meditec. The device is directly connected to the Ceodeux Meditec ALPICONNECT or ALPINOX and MINIOX to control the flow of oxygen from portable oxygen cylinders and the hospital's pipeline system.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Medical Gas Market size was valued at USD 13.4 billion in 2023 and is poised to grow from USD 15.1 billion in 2024 to USD 26.34 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032). 

Due to the existence of a small number of significant companies, the market is moderately consolidated. Leading players also participate in partnerships, product launches, mergers, and acquisitions to expand their product lines. For instance, Air Liquide S.A. agreed to buy South Africa's biggest oxygen production facility in June 2021. Strategically, Air Liquide and Sasol agreed that Air Liquide would acquire and run the plant. This plan is expected to improve the company's total manufacturing capability and solidify its position in the market. As a result, the market is expected to grow over the course of the projected period thanks to various strategies adopted by top players. The following are a few of the leading companies in the medical gas market. 'Linde plc (UK) ', 'Air Liquide (France) ', 'Taiyo Nippon Sanso Corporation (Japan) ', 'Air Products and Chemicals, Inc. (USA) ', 'Atlas Copco AB (Sweden) ', 'Messer Group GmbH (Germany) ', 'Matheson Tri-Gas Inc. (USA) (owned by Taiyo Nippon Sanso) ', 'SOL S.p.A. (Italy) ', 'GCE Group (Sweden) ', 'Amico Group of Companies (Canada) ', 'Praxair, Inc. (USA) (merged with Linde) ', 'INOX Air Products Pvt Ltd (India) ', 'Norco, Inc. (USA) ', 'Genstar Technologies Company, Inc. (USA) ', 'Southern Gas Limited (India) ', 'Calox Inc. (USA) ', 'Ellenbarrie Industrial Gases Ltd. (India) ', 'Steelman Gases Pvt. Ltd. (India) ', 'Butler Gas Products Company (USA) ', 'SCI Analytical, Inc. (USA) '

The number of people worldwide who suffer from obesity and other related problems has considerably increased in recent years due to changes in lifestyle and eating habits. Between 2021 and 2022, the prevalence of obesity nearly tripled worldwide. Over 1.9 billion persons (18 years and older) were allegedly overweight globally in 2021, according to the WHO. Over 650 million of these were deemed to be obese. Additionally, 340 million kids and teenagers worldwide, aged 5 to 19, were reported to be overweight or obese in 2021.

The US Food and Drug Administration (FDA) Safety and Innovation Act, which went into effect in July 2021 and gives manufacturers the ability to control costs and submit applications for intellectual property rights for new medical gas and equipment products, is a major factor fueling the market's expansion. Additionally, the market is growing due to an increase in home healthcare applications and an aging population. Additionally, the fast urbanization, rise in the prevalence of cigarette use, and rise in the incidence of respiratory ailments all contribute to the market's expansion. However, it is projected that the market expansion will be hampered by the widespread helium shortage, modifications to the requirements for medical gas calibration, and diminishing government reimbursements for respiratory therapy. On the other hand, it is expected that in the near future, market growth in emerging nations and technical advances in medical research would offer attractive opportunities.

The medical gas market was dominated by North America, which had a revenue share of 35.9 % in 2021 and is expected to rise at a significant rate during the forecast period. The increased use of medicinal gases in the treatment of respiratory conditions including COPD and asthma is responsible for this consistent growth. During the expected timeframe, it is expected that the demand for medical gases in the US will increase due to the increased prevalence of COPD, asthma, and other medical illnesses like cardiovascular and lifestyle-related diseases. Additionally, the US has captured the largest share of the market thanks to the availability of state-of-the-art healthcare facilities, notably intensive care units, a well-established market, and a growing geriatric population.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Medical Gas Equipment Market
Buy Now GET FREE SAMPLE
Medical Gases and Equipment Market
Buy Now GET FREE SAMPLE
Gas Treatment Market
Buy Now GET FREE SAMPLE
Specialty Gases Market
Buy Now GET FREE SAMPLE
Natural Gas Market
Buy Now GET FREE SAMPLE
Medical Fluid Bags Market
Buy Now GET FREE SAMPLE
Gas Masks Market
Buy Now GET FREE SAMPLE
Medical Carts Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Medical Gas Market

Report ID: SQSG35B2022

$5,300
BUY NOW GET FREE SAMPLE